Skip to main content
Sailong Pharmaceutical Group Co., Ltd. logo

Sailong Pharmaceutical Group Co., Ltd. — Investor Relations & Filings

Ticker · 002898 ISIN · CNE1000032S5 LEI · 8368004F5Y6BSB6US681 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,116 across all filing types
Latest filing 2023-03-14 Governance Information
Country CN China
Listing Shenzhen Stock Exchange 002898

About Sailong Pharmaceutical Group Co., Ltd.

https://www.sailong.cn

Sailong Pharmaceutical Group Co., Ltd. is a pharmaceutical enterprise focused on the research, development, production, and marketing of high-end generic drugs and innovative formulations. The company maintains an integrated industrial chain encompassing active pharmaceutical ingredients (APIs) and finished dosage forms. Its product portfolio primarily targets therapeutic areas such as cardiovascular and cerebrovascular diseases, the digestive system, and anti-infective treatments. Key products include Monosialotetrahexosylganglioside Sodium Injection and Pantoprazole Sodium for Injection. The group emphasizes technological innovation and quality control to provide clinical solutions for complex medical conditions.

Recent filings

Filing Released Lang Actions
《董事会秘书工作细则》
Governance Information Classification · 100% confidence The document is titled as the "Board Secretary Work Rules" for a company, detailing the duties, qualifications, rights, and obligations of the board secretary. It is a governance-related internal regulation document, not a financial report, announcement, or meeting material. It does not contain financial data, voting results, or any regulatory filings. It is a governance practice document outlining internal rules and responsibilities related to corporate governance. Therefore, it fits best under the Governance Information (CGR) category.
2023-03-14 Chinese
《内部审计制度》
Governance Information Classification · 95% confidence The document is titled '赛隆药业集团股份有限公司 内部审计制度' which translates to 'Internal Audit System of Sailong Pharmaceutical Group Co., Ltd.' It details the internal audit policies, responsibilities, procedures, and oversight mechanisms within the company. It references relevant laws and regulations, internal audit department structure, duties, and reporting requirements. The document is a comprehensive internal control and audit policy manual rather than a financial report, earnings release, or announcement. It does not contain financial statements or results, nor is it a brief announcement or presentation. It is a regulatory or governance-related document outlining internal audit governance and procedures. Therefore, the most appropriate classification is Governance Information (CGR). The document length (6315 characters) supports it being a full policy document rather than a short announcement.
2023-03-14 Chinese
公司章程修正案
Governance Information Classification · 95% confidence The document is a formal announcement regarding amendments to the company's Articles of Association (公司章程) specifically related to changes in the business scope as required by a regulatory notice from the Zhuhai Market Supervision Administration. It details the before and after text of the relevant article in the Articles of Association and mentions that the changes require shareholder approval and subsequent registration with the market supervision department. The document is short (1122 characters) and does not contain financial data, audit information, or detailed management discussion. It is not a full report but an announcement of governance-related changes to the company's internal rules. Therefore, it fits best under Governance Information (CGR).
2023-03-14 Chinese
2023年第一次临时股东大会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a formal announcement of the resolutions passed at the 2023 first extraordinary general meeting (临时股东大会) of the company 赛隆药业集团股份有限公司. It details the meeting date, voting procedures, attendance, and the voting results on various proposals, including the election of independent directors and supervisors, and approval of guarantees for financing leasing business. It also includes legal opinions confirming the legality of the meeting and voting process. The document does not contain financial statements or detailed financial analysis, nor is it a presentation or report of financial results. It is a formal declaration of voting results from a shareholders' meeting. Therefore, the appropriate classification is Declaration of Voting Results & Voting Rights Announcements (DVA). The document length is short (2356 characters), but it contains full voting results, not just a notice of report publication or a brief announcement, so it is not RPA or RNS. Confidence is high due to clear voting results and meeting details.
2023-03-02 Chinese
关于选举公司第三届监事会主席的公告
Board/Management Information Classification · 100% confidence The document is an announcement regarding the election of the chairman of the company's third supervisory board. It includes details about the elected individual, his qualifications, and compliance with relevant laws and regulations. There is no financial data, no mention of financial results, reports, or regulatory filings beyond this announcement. The content fits the category of Board/Management Information as it relates to changes in the company's supervisory board leadership.
2023-03-02 Chinese
赛隆药业2023第一次临时股东大会法律意见书
Regulatory Filings Classification · 95% confidence The document is a legal opinion letter issued by a law firm regarding the legality and validity of the procedures, attendance, and voting results of the 2023 first extraordinary general meeting (临时股东大会) of the company. It details the convening, attendance, voting procedures, and results of the shareholders' meeting. It does not contain financial statements or management discussion of financial results. It is not a report of financial performance or an earnings release. It is not a proxy solicitation or voting results announcement per se, but a legal opinion on the meeting's procedural compliance. Given the nature of the document as a legal opinion on a shareholders meeting, it best fits under Regulatory Filings (RNS), which is the fallback for miscellaneous regulatory or compliance documents that do not fit other categories.
2023-03-02 Chinese

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.